• VOLUNTARY ANNOUNCEMENT - The first enrollment for confirmatory clinical trials of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System had been completed in China

   

• NOTICE OF BOARD MEETING

   

• DISCLOSEABLE TRANSACTION - SUBSCRIPTION OF PRINCIPAL-PROTECTED STRUCTURED DEPOSIT

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2022

   

• ADOPTION OF THE 2022 SHARE AWARD SCHEME

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2022

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2021

   

• VOLUNTARY ANNOUNCEMENT - AMENDMENTS TO AGREEMENTS ENTERED INTO WITH MEDTRONIC

   

• GRANT OF SHARE OPTIONS

   

• MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2021